title: Permeability characteristics of hemoglobin derivatives across cultured endothelial cell monolayers.
abstract: To better understand the vascular activity of hemoglobin-based (Hb-based) oxygen carriers, the endothelial permeability characteristics of Hb derivatives having various molecular masses were defined by using monolayers of bovine endothelial cells cultured on microporous membranes. The endothelial permeability of unmodified bovine Hb was almost twice that of bovine serum albumin. Intramolecularly cross-linked human Hb showed slightly but significantly reduced permeability as compared with unmodified bovine Hb. Polyethyleneglycol modification or haptoglobin binding to Hb further reduced the permeability. These properties were intensified in conditions in which the endothelial barrier function was reduced by pretreatment with either interleukin-6 (100 ng/mL, 21 hours) or lipopolysaccharide (1 microg/mL, 10 hours). In contrast, there was little permeability of liposome-encapsulated Hb, and it was almost unaffected by the pretreatments. These data provide the first information that Hb derivatives with smaller molecular masses show larger transendothelial flux. Because Hb is a potent scavenger of endothelium-derived relaxing factor (EDRF), our observations support the idea that smaller Hb-based acellular oxygen carriers are potent vasoconstrictors as a result of abluminal EDRF scavenging.
authors.affiliation: Department of Cell Processing, Institute of Medical Science, University of Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Nakai
authors.forename: I
authors.initials: I
authors.lastname: Sakuma
authors.forename: T
authors.initials: T
authors.lastname: Ohta
authors.forename: J
authors.initials: J
authors.lastname: Ando
authors.forename: A
authors.initials: A
authors.lastname: Kitabatake
authors.forename: Y
authors.initials: Y
authors.lastname: Nakazato
authors.forename: T A
authors.initials: TA
authors.lastname: Takahashi
mesh_terms: D000818:Animals; D001120:Arginine / Q000494:pharmacology; D001802:Blood Substitutes / Q000302:isolation & purification / Q000378:metabolism; D002417:Cattle; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004337:Drug Carriers; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism*; D004926:Escherichia coli; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D015850:Interleukin-6 / Q000494:pharmacology; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D008081:Liposomes; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism; D010539:Permeability; D012710:Serum Albumin, Bovine / Q000378:metabolism
chemical_list: D001802:Blood Substitutes; D004337:Drug Carriers; D006454:Hemoglobins; D015850:Interleukin-6; D008070:Lipopolysaccharides; D008081:Liposomes; D012710:Serum Albumin, Bovine; D009569:Nitric Oxide; D001120:Arginine; D007770:L-Lactate Dehydrogenase; D019331:NG-Nitroarginine Methyl Ester